¼¼°èÀÇ ÇÇºÎ¾Ï Áø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, °Ë»ç À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, Àü¸Á°ú ¿¹Ãø(2024-2031³â)
Global Skin Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type, By Test Type, By End-use, By Regional Outlook and Forecast, 2024 - 2031
»óǰÄÚµå : 1522085
¸®¼­Ä¡»ç : KBV Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 219 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,600 £Ü 5,208,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,320 £Ü 6,250,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,048 £Ü 8,750,000
PDF (Corporate User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇÇºÎ¾Ï Áø´Ü ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ Áß 5.3%ÀÇ CAGR·Î ½ÃÀå ¼ºÀåÇϸç, 2031³â±îÁö 128¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó ÇÇºÎ¾Ï ¹ßº´·üÀº ƯÈ÷ 50¼¼ À̻󿡼­ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, º¸´Ù Á¾ÇÕÀûÀÎ Áø´Ü ¹æ¹ý ¹× ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª ÇǺΰæ, °øÃÊÁ¡ Çö¹Ì°æ, ÷´Ü ¿µ»ó ½Ã½ºÅÛ°ú °°Àº ÷´Ü Àåºñ´Â ÇǺξÏÀ» Á¤È®Çϰí Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â ÃÖ÷´Ü ±â¼úÀÔ´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ÅøÀÇ °³¹ß ¹× Á¦Á¶¿¡´Â ¸¹Àº ÅõÀÚ°¡ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå °¡°Ý¿¡ ¹Ý¿µµÇ¾î ÀÖ½À´Ï´Ù.

À¯Çüº° Àü¸Á

¾Ï À¯Çü¿¡ µû¶ó ½ÃÀåÀº Èæ»öÁ¾°ú ºñÈæ»öÁ¾À¸·Î ºÐ·ùµË´Ï´Ù. ºñÈæ»öÁ¾ ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 72%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. °¡Àå ÈçÇÑ µÎ °¡Áö ÇüÅÂÀÇ ÇǺξÏÀÎ ±âÀú¼¼Æ÷¾Ï(BCC)°ú ÆíÆò»óÇǾÏ(SCC)ÀÌ ÀÌ ºÎ¹®À» À̲ô´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

°Ë»ç À¯Çü Àü¸Á

°Ë»ç À¯Çü¿¡ µû¶ó ½ÃÀåÀº ÇÇºÎ°æ °Ë»ç, ÇǺΠ»ý°Ë, ¸²ÇÁÀý »ý°Ë, ¿µ»ó °Ë»ç µîÀ¸·Î ºÐ·ùµË´Ï´Ù. ¿µ»ó °Ë»ç ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 27%ÀÇ ¸ÅÃâ Á¡À¯À²À» ±â·ÏÇß½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Àü¸Á

ÃÖÁ¾ ¿ëµµº°·Î ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, ¿¬±¸¼Ò, ±âŸ·Î ³ª´¹´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº 2023³â ½ÃÀå¿¡¼­ 51%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀáÀçÀûÀÎ ÇǺξÏÀ» Æ÷ÇÔÇÑ ÇǺΠÁúȯÀ¸·Î ÀÎÇØ Ä¡·á°¡ ÇÊ¿äÇÑ È¯ÀÚµéÀº º´¿ø ¹× Ŭ¸®´ÐÀ» ÁÖ¿ä Ä¡·á Àå¼Ò·Î ÀÌ¿ëÇϰí ÀÖ½À´Ï´Ù.

Áö¿ª Àü¸Á

Áö¿ªº°·Î ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ³ª´µ¾î ºÐ¼®µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2023³â ÇÇºÎ¾Ï Áø´Ü ½ÃÀå¿¡¼­ 23%ÀÇ ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È£ÁÖ¿Í °°Àº ±¹°¡¿¡¼­´Â Àڿܼ± ³ëÃâÀÌ ¸¹±â ¶§¹®¿¡ ÇÇºÎ¾Ï ¹ß»ý·üÀÌ ³ôÁö¸¸ Áß±¹, Àεµ, ÀϺ»°ú °°Àº ½ÅÈï ½ÃÀå¿¡¼­´Â ÇÇºÎ¾Ï »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦2Àå ½ÃÀå °³°ü

Á¦3Àå ½ÃÀå °³¿ä

Á¦4Àå ¼¼°è ½ÃÀå : À¯Çüº°

Á¦5Àå ¼¼°è ½ÃÀå : °Ë»ç À¯Çüº°

Á¦6Àå ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦7Àå ¼¼°è ½ÃÀå : Áö¿ªº°

Á¦8Àå ±â¾÷ °³¿ä

Á¦9Àå ÇÇºÎ¾Ï Áø´Ü ½ÃÀåÀÇ ¼º°ø Çʼö Á¶°Ç

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Skin Cancer Diagnostics Market size is expected to reach $12.8 billion by 2031, rising at a market growth of 5.3% CAGR during the forecast period.

A combination of high skin cancer prevalence, advanced healthcare infrastructure, and strong government support drives the market in this region. Skin cancer, particularly non-melanoma and melanoma is highly prevalent in the United States, with millions of cases diagnosed annually. This widespread incidence necessitates extensive diagnostic services. Advanced healthcare systems in North America, particularly in the United States and Canada, are equipped with state-of-the-art diagnostic tools such as dermatoscopes, confocal microscopes, and AI-enhanced imaging systems, which enhance diagnostic accuracy and efficiency. Thus, the North America region acquired 37% revenue share in the market 2023.

The proportion of people diagnosed with melanoma around the world has been gradually climbing, which has led to a rise in the demand for cutting-edge diagnostic tools and technology. Globally, 132,000 melanoma skin cancers and 2 to 3 million non-melanoma skin cancers are diagnosed annually, according to the World Health Organization (WHO).

Additionally, it is projected that the incidence of skin cancer will increase, particularly among those who are 50 years of age or older, as the global population advances in age. Consequently, the demand for more comprehensive diagnostic methods and healthcare services will increase.

However, advanced equipment such as dermatoscopes, confocal microscopes, and sophisticated imaging systems represent cutting-edge technology for accurate and early skin cancer detection. However, the development and manufacturing of these tools involve substantial investment, which is reflected in their market prices.

Type Outlook

Based on cancer type, the market is characterized into melanoma and non-melanoma. The non-melanoma segment garnered 72% revenue share in the market in 2023. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), the two most prevalent forms of skin cancer, are the primary factors driving the segment.

Test Type Outlook

On the basis of test type, the market is classified into dermatoscopy, skin biopsy, lymph node biopsy, imaging tests, and others. The imaging tests segment recorded 27% revenue share in the market in 2023.

End-use Outlook

By end-use, the market is divided into hospital & clinics, laboratories, and others. The hospital & clinics segment witnessed 51% revenue share in the market in 2023. Patients who require medical attention for skin issues, including potential skin cancer, are served by hospitals and clinics as their primary sites of care.

Reginal Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific segment acquired 23% revenue share in the skin cancer diagnostics market in 2023. Countries like Australia face high skin cancer rates due to significant UV exposure while emerging markets such as China, India, and Japan are witnessing increasing skin cancer cases.

List of Key Companies Profiled

Global Skin Cancer Diagnostics Market Report Segmentation

By Type

By Test Type

By End-use

By Geography

Table of Contents

Chapter 1. Market Scope & Methodology

Chapter 2. Market at a Glance

Chapter 3. Market Overview

Chapter 4. Global Skin Cancer Diagnostics Market by Type

Chapter 5. Global Skin Cancer Diagnostics Market by Test Type

Chapter 6. Global Skin Cancer Diagnostics Market by End-use

Chapter 7. Global Skin Cancer Diagnostics Market by Region

Chapter 8. Company Profiles

Chapter 9. Winning Imperatives for Skin Cancer Diagnostics Market

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â